Overview

Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This study will explore information on whether changing the salt formulation of indacaterol affects the incidence of post-inhalation cough.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis
Treatments:
Maleic acid